GB0120150D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0120150D0
GB0120150D0 GBGB0120150.8A GB0120150A GB0120150D0 GB 0120150 D0 GB0120150 D0 GB 0120150D0 GB 0120150 A GB0120150 A GB 0120150A GB 0120150 D0 GB0120150 D0 GB 0120150D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0120150.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GBGB0120150.8A priority Critical patent/GB0120150D0/en
Publication of GB0120150D0 publication Critical patent/GB0120150D0/en
Priority to US10/486,910 priority patent/US20040234538A1/en
Priority to CA002457163A priority patent/CA2457163A1/en
Priority to EP02767386A priority patent/EP1417226A1/en
Priority to JP2003521262A priority patent/JP2005502339A/ja
Priority to PCT/EP2002/009122 priority patent/WO2003016340A1/en
Priority to US11/623,498 priority patent/US20070122423A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0120150.8A 2001-08-17 2001-08-17 Novel compounds Ceased GB0120150D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB0120150.8A GB0120150D0 (en) 2001-08-17 2001-08-17 Novel compounds
US10/486,910 US20040234538A1 (en) 2001-08-17 2002-08-15 Derp1 and proderp1 allergen derivatives
CA002457163A CA2457163A1 (en) 2001-08-17 2002-08-15 Derp1 and proderp1 allergen derivatives
EP02767386A EP1417226A1 (en) 2001-08-17 2002-08-15 Derp1 and proderp1 allergen derivatives
JP2003521262A JP2005502339A (ja) 2001-08-17 2002-08-15 Ｄｅｒｐ１およびｐｒｏｄｅｒｐ１アレルゲン誘導体
PCT/EP2002/009122 WO2003016340A1 (en) 2001-08-17 2002-08-15 Derp1 and proderp1 allergen derivatives
US11/623,498 US20070122423A1 (en) 2001-08-17 2007-01-16 Derp1 and proderp1 allergen derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0120150.8A GB0120150D0 (en) 2001-08-17 2001-08-17 Novel compounds

Publications (1)

Publication Number Publication Date
GB0120150D0 true GB0120150D0 (en) 2001-10-10

Family

ID=9920622

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0120150.8A Ceased GB0120150D0 (en) 2001-08-17 2001-08-17 Novel compounds

Country Status (6)

Country Link
US (2) US20040234538A1 (enExample)
EP (1) EP1417226A1 (enExample)
JP (1) JP2005502339A (enExample)
CA (1) CA2457163A1 (enExample)
GB (1) GB0120150D0 (enExample)
WO (1) WO2003016340A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003300681A1 (en) * 2002-10-02 2004-05-04 Diamyd Medical Ab Formulation of glutarmic acid decarboxylase (gad65) and serum albumin
GB0304424D0 (en) * 2003-02-26 2003-04-02 Glaxosmithkline Biolog Sa Novel compounds
CA2523402A1 (en) * 2003-04-25 2004-11-11 Novozymes A/S Group 1 mite polypeptide variants
WO2006026994A1 (en) * 2004-09-09 2006-03-16 Alk-Abelló A/S Crystal structure of house dust mite allergen der p 1
FR2889592B1 (fr) * 2005-08-03 2008-09-12 Inst Nat Agronomique Paris Gri Procede pour tester l'aptitude d'une composition a provoquer une reaction allergique croisee avec un allergene derive de l'arachide
EP1835031A1 (en) * 2006-03-14 2007-09-19 Paul-Ehrlich-Institut Bundesamt für Sera und Impfstoffe Use of a recombinant modified vaccinia virus Ankara (MVA) for the treatment of type I hypersensitivity in a living animal including humans
WO2008154350A2 (en) * 2007-06-08 2008-12-18 Alba Therapeutics Corporation Use of tight junction agonists to suppress immune responses
NL2014882B1 (en) 2015-05-29 2017-01-31 Citeq B V Allergy-specific immunotherapy compositions for use in the treatment of house-dust mite allergy.
GB201806819D0 (en) * 2018-04-26 2018-06-13 Univ Gent Compositions for active immunotherapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5433948A (en) * 1990-02-13 1995-07-18 Thomas; Wayne R. Cloning and sequencing of allergens of dermatophagoides (house dust mite)
US6849427B1 (en) * 1993-03-12 2005-02-01 Immulogic Pharmaceutical Corp. Nucleic acids encoding a house dust mite allergen, Der p VII, and uses therefor
EP1043032A3 (en) * 1994-07-29 2000-11-15 Kenneth Houlbrook Use of moisture and heat for de-naturing house dust mite (HDM) allergen
US5670356A (en) * 1994-12-12 1997-09-23 Promega Corporation Modified luciferase
US5762943A (en) * 1996-05-14 1998-06-09 Ribi Immunochem Research, Inc. Methods of treating type I hypersensitivity using monophosphoryl lipid A
GB9724531D0 (en) * 1997-11-19 1998-01-21 Smithkline Biolog Novel compounds
US6455686B1 (en) * 1998-04-17 2002-09-24 Heska Corporation Dermatophagoides nucleic acid molecules, proteins and uses thereof
WO2001029078A2 (en) * 1999-10-15 2001-04-26 Heska Corporation Method for production and use of mite group 1 proteins
GB0014288D0 (en) * 2000-06-10 2000-08-02 Smithkline Beecham Biolog Vaccine

Also Published As

Publication number Publication date
JP2005502339A (ja) 2005-01-27
CA2457163A1 (en) 2003-02-27
WO2003016340A1 (en) 2003-02-27
US20040234538A1 (en) 2004-11-25
EP1417226A1 (en) 2004-05-12
US20070122423A1 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
GB0105895D0 (en) Novel compounds
AU2002359165A8 (en) Novel compounds
GB0106586D0 (en) Novel compounds
GB0120150D0 (en) Novel compounds
GB0104259D0 (en) Novel compounds
GB0102713D0 (en) Novel compounds
GB0102470D0 (en) Novel compounds
GB0103866D0 (en) Novel compounds
GB0105095D0 (en) Novel compounds
GB0107659D0 (en) Novel compounds
GB0107116D0 (en) Novel compounds
GB0106613D0 (en) Novel compounds
GB0107389D0 (en) Novel compounds
GB0106584D0 (en) Novel compounds
GB0106451D0 (en) Novel compounds
GB0106447D0 (en) Novel compounds
GB0106158D0 (en) Novel Compounds
GB0106157D0 (en) Novel compounds
GB0106156D0 (en) Novel compounds
GB0106155D0 (en) Novel Compounds
GB0102714D0 (en) Novel compounds
GB0105634D0 (en) Novel compounds
GB0105234D0 (en) Novel compounds
GB0107626D0 (en) Novel compounds
GB0104970D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)